rs41348347

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000361.3(THBD):​c.1456G>T​(p.Asp486Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00202 in 1,612,354 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D486E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0029 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 69 hom. )

Consequence

THBD
NM_000361.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:8

Conservation

PhyloP100: -0.842

Publications

32 publications found
Variant links:
Genes affected
THBD (HGNC:11784): (thrombomodulin) The protein encoded by this intronless gene is an endothelial-specific type I membrane receptor that binds thrombin. This binding results in the activation of protein C, which degrades clotting factors Va and VIIIa and reduces the amount of thrombin generated. Mutations in this gene are a cause of thromboembolic disease, also known as inherited thrombophilia. [provided by RefSeq, Jul 2008]
THBD Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome with thrombomodulin anomaly
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • thrombomodulin-related bleeding disorder
    Inheritance: AR, AD, Unknown Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002846241).
BP6
Variant 20-23048049-C-A is Benign according to our data. Variant chr20-23048049-C-A is described in ClinVar as Benign. ClinVar VariationId is 12714.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00288 (439/152378) while in subpopulation AMR AF = 0.023 (352/15310). AF 95% confidence interval is 0.021. There are 10 homozygotes in GnomAd4. There are 221 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR,AD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
THBDNM_000361.3 linkc.1456G>T p.Asp486Tyr missense_variant Exon 1 of 1 ENST00000377103.3 NP_000352.1 P07204

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
THBDENST00000377103.3 linkc.1456G>T p.Asp486Tyr missense_variant Exon 1 of 1 6 NM_000361.3 ENSP00000366307.2 P07204
ENSG00000296483ENST00000739851.1 linkn.795+2770G>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00287
AC:
437
AN:
152260
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000313
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00924
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00838
AC:
2054
AN:
245174
AF XY:
0.00646
show subpopulations
Gnomad AFR exome
AF:
0.000515
Gnomad AMR exome
AF:
0.0512
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0114
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000227
Gnomad OTH exome
AF:
0.00518
GnomAD4 exome
AF:
0.00193
AC:
2820
AN:
1459976
Hom.:
69
Cov.:
30
AF XY:
0.00174
AC XY:
1261
AN XY:
726292
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33466
American (AMR)
AF:
0.0456
AC:
2028
AN:
44520
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26056
East Asian (EAS)
AF:
0.0107
AC:
423
AN:
39632
South Asian (SAS)
AF:
0.00122
AC:
105
AN:
86100
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52770
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5760
European-Non Finnish (NFE)
AF:
0.000139
AC:
155
AN:
1111394
Other (OTH)
AF:
0.00159
AC:
96
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
225
451
676
902
1127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00288
AC:
439
AN:
152378
Hom.:
10
Cov.:
33
AF XY:
0.00297
AC XY:
221
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41596
American (AMR)
AF:
0.0230
AC:
352
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00927
AC:
48
AN:
5180
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68038
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00150
Hom.:
2
Bravo
AF:
0.00563
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00649
AC:
787
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jul 27, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26034596, 7811989, 19625716, 25135378, 20595690, 23332921) -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

THBD: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Thrombomodulin-related bleeding disorder Uncertain:1
Aug 01, 2002
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
Oct 24, 2019
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kidney disorder Benign:1
Mar 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

THBD-related disorder Benign:1
Jun 05, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Atypical hemolytic-uremic syndrome with thrombomodulin anomaly Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
0.48
DANN
Benign
0.73
DEOGEN2
Benign
0.24
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.43
T
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
1.8
L
PhyloP100
-0.84
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.98
N
REVEL
Benign
0.24
Sift
Benign
0.27
T
Sift4G
Benign
0.091
T
Polyphen
0.54
P
Vest4
0.23
MVP
0.25
ClinPred
0.0034
T
GERP RS
-5.3
Varity_R
0.053
gMVP
0.56
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41348347; hg19: chr20-23028686; COSMIC: COSV104690727; API